Defilade Capital Management L.P. Trims Holdings in Align Technology, Inc. $ALGN

Defilade Capital Management L.P. decreased its holdings in shares of Align Technology, Inc. (NASDAQ:ALGN) by 47.4% in the first quarter, HoldingsChannel reports. The firm owned 67,332 shares of the medical equipment provider’s stock after selling 60,728 shares during the quarter. Align Technology makes up 1.6% of Defilade Capital Management L.P.’s investment portfolio, making the stock its 27th biggest position. Defilade Capital Management L.P.’s holdings in Align Technology were worth $11,543,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of ALGN. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in shares of Align Technology by 4.8% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 10,222 shares of the medical equipment provider’s stock valued at $1,624,000 after acquiring an additional 469 shares in the last quarter. Focus Partners Wealth boosted its holdings in Align Technology by 5.2% in the first quarter. Focus Partners Wealth now owns 3,062 shares of the medical equipment provider’s stock valued at $486,000 after acquiring an additional 151 shares in the last quarter. Sivia Capital Partners LLC purchased a new position in Align Technology during the 2nd quarter valued at $204,000. EverSource Wealth Advisors LLC increased its position in Align Technology by 55.7% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 531 shares of the medical equipment provider’s stock valued at $101,000 after purchasing an additional 190 shares during the period. Finally, First Trust Advisors LP increased its position in Align Technology by 201.7% during the 2nd quarter. First Trust Advisors LP now owns 88,270 shares of the medical equipment provider’s stock valued at $16,712,000 after purchasing an additional 59,010 shares during the period. Hedge funds and other institutional investors own 88.43% of the company’s stock.

Key Align Technology News

Here are the key news stories impacting Align Technology this week:

• Positive Sentiment: Q2 results exceeded expectations. Align reported adjusted earnings of $2.64 per share and revenue of approximately $1.06 billion, topping consensus estimates. Revenue increased 4.3% year over year, while record Clear Aligner shipments and improved non-GAAP margins supported profitability. Align Technology Q2 Earnings and Revenues Top Estimates
• Positive Sentiment: Digital orthodontics remains a growth focus. Management highlighted expanding digital workflows, connected orthodontic tools and long-term opportunities for Invisalign, iTero scanners and exocad software. The company’s 2026 outlook was reaffirmed, while an orthodontic summit showcased its product and technology strategy. ALGN Q2 Earnings Call Highlights Digital Growth Push
• Positive Sentiment: Board changes could improve shareholder value. Following discussions with Elliott Investment Management, Align plans to add three independent directors and conduct an operational review. The initiatives may increase accountability, improve execution and identify opportunities to enhance returns. Align Technology to Overhaul Board Following Engagement with Elliott
• Neutral Sentiment: Valuation is viewed as more attractive after the pullback. Some analysts see ALGN as reasonably valued, but believe the stock needs faster growth to generate sustained upside. Align Technology: Attractively Valued, But Growth Still Needs To Pick Up
• Negative Sentiment: Near-term guidance and execution remain concerns. Third-quarter revenue guidance of roughly $1.0 billion was described as slightly below or around expectations, limiting the benefit of the earnings beat.
• Negative Sentiment: Systems weakness is capping upside. Analysts noted softer scanner and systems performance, along with pricing pressure, despite strong Clear Aligner volumes. Needham maintained a Hold rating. Align Technology Hold Rating Maintained
• Negative Sentiment: Growth is still relatively modest. Investors may remain cautious because revenue growth has not yet accelerated enough to justify a more bullish outlook, even with improving margins and record aligner shipments.

Analyst Ratings Changes

ALGN has been the subject of several research analyst reports. Needham & Company LLC reaffirmed a “hold” rating on shares of Align Technology in a research report on Thursday. Evercore boosted their price target on shares of Align Technology from $200.00 to $220.00 in a research report on Thursday, April 30th. BMO Capital Markets began coverage on shares of Align Technology in a research report on Wednesday, July 8th. They set an “outperform” rating and a $209.00 price target on the stock. Zacks Research downgraded shares of Align Technology from a “strong-buy” rating to a “hold” rating in a research note on Thursday, July 16th. Finally, Weiss Ratings upgraded shares of Align Technology from a “hold (c-)” rating to a “hold (c)” rating in a report on Friday, July 17th. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and six have assigned a Hold rating to the company. According to data from MarketBeat, Align Technology presently has an average rating of “Moderate Buy” and an average target price of $206.36.

Align Technology Stock Performance

Shares of Align Technology stock opened at $169.16 on Monday. Align Technology, Inc. has a 12 month low of $122.00 and a 12 month high of $200.43. The firm has a market capitalization of $12.12 billion, a P/E ratio of 29.42, a P/E/G ratio of 1.78 and a beta of 1.65. The business has a fifty day simple moving average of $174.55 and a two-hundred day simple moving average of $175.23.

Align Technology (NASDAQ:ALGN) last released its earnings results on Wednesday, July 29th. The medical equipment provider reported $2.64 earnings per share for the quarter, topping analysts’ consensus estimates of $2.62 by $0.02. The firm had revenue of $1.06 billion for the quarter, compared to the consensus estimate of $1.05 billion. Align Technology had a net margin of 9.99% and a return on equity of 15.86%. The company’s revenue was up 4.3% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.49 EPS. Analysts predict that Align Technology, Inc. will post 9.48 earnings per share for the current year.

Align Technology declared that its Board of Directors has authorized a share buyback plan on Wednesday, April 29th that allows the company to buyback $200.00 million in shares. This buyback authorization allows the medical equipment provider to buy up to 1.6% of its shares through open market purchases. Shares buyback plans are usually a sign that the company’s board believes its shares are undervalued.

Align Technology Company Profile

Align Technology, Inc (NASDAQ: ALGN) pioneered the use of digital technology in orthodontics through the development of the Invisalign system, a series of clear, removable aligners that provide an alternative to traditional metal braces. Since its founding in 1997 by Zia Chishti and Kelsey Wirth, the Tempe, Arizona–based company has expanded its focus to include intraoral scanners, CAD/CAM software for dental laboratories and comprehensive digital dentistry solutions.

The company’s signature Invisalign system leverages 3D imaging and computer-aided design (CAD) to create customized aligners that gradually reposition teeth, improving patient comfort and treatment predictability.